U.S. IT Stock News

Centerspace (NYSE: CSR) has declared a regular quarterly dividend of US$0.77 per share and confirmed it is undergoing a formal strategic review of its operations. This combination of continued cash returns to investors and a potential reshaping of the business raises fresh questions about how Centerspace’s portfolio and capital priorities may evolve. Next, we’ll examine how the ongoing strategic review might influence Centerspace’s existing investment narrative around rental demand, capital...

In early January 2026, Adstra announced a collaboration with Stagwell’s The Marketing Cloud and Databricks to bring Adstra’s Conexa Identity Network into Databricks Clean Rooms, while Stagwell also unveiled “The Machine,” an AI-powered agentic operating system that layers onto existing marketing tools and is slated for enterprise deployment in Q1 2025. Stagwell additionally consolidated media and commerce leadership under a new Global Chair and spun SPORT BEACH into a standalone business...

In recent days, Chord Energy has highlighted resilient operations, reaffirmed guidance, and continued returning capital via dividends and buybacks, reinforcing its disciplined approach amid a volatile oil market. A key takeaway is how Chord Energy’s strong cash generation and measured capital spending are supporting shareholder-focused policies while keeping the balance sheet firm. We’ll now examine how this renewed focus on cash generation and shareholder returns affects Chord Energy’s...

Itron (ITRI) stock is back in focus after the company announced a multi year collaboration in Thessaloniki, Greece, where its smart water meters and data platforms will support a large scale digital water transformation. See our latest analysis for Itron. The Thessaloniki project lands at a time when Itron’s 1 day share price return of 1.2% and 7 day share price return of 6.0% contrast with a 90 day share price decline of 19.4%. Meanwhile, the 3 year total shareholder return of 70.6% stands...

Navient (NAVI) is in focus after announcing a reshuffle of its senior team, with long time executive Steve Hauber stepping into the chief financial officer and principal accounting officer roles. See our latest analysis for Navient. The leadership reshuffle lands at a time when Navient’s 90 day share price return of 9.79% and 30 day share price return of 5.47% point to building momentum, even as the 3 year total shareholder return of a 14.69% decline contrasts with a 5 year total shareholder...

In early January 2026, Comcast expanded its converged Xfinity network to connect more than 2,300 homes and businesses in Centreville, Maryland, as part of a broader buildout that will ultimately reach over 16,000 locations across Queen Anne’s County and extend multi-gigabit, symmetrical internet plus its full residential and business service suite. Beyond faster broadband, Comcast is tying this buildout to digital inclusion programs like Internet Essentials and Lift Zones, signaling that its...

Nicolet Bankshares recently reported a strong Q3, with revenues exceeding analysts’ expectations by 6.5% and net interest income also beating forecasts, underscoring solid operating performance across its regional footprint. This performance sets Nicolet Bankshares apart from many regional peers, highlighting the importance of its net interest income strength in a challenging banking landscape. We’ll now examine how this stronger-than-expected net interest income shapes Nicolet Bankshares’...

Las Vegas Sands Corp. recently entered the spotlight ahead of its fiscal fourth-quarter 2025 earnings release, with analysts expecting diluted earnings of US$0.78 per share, suggesting double-digit bottom-line growth compared with the same period a year earlier. Analysts attribute these stronger profit expectations largely to robust operating performance at The Londoner Macao and Marina Bay Sands in Singapore, highlighting how these flagship properties are shaping the company’s earnings...

YETI Holdings (YETI) shares recently moved higher alongside a broader market rally, as investors responded to easing geopolitical tensions linked to Venezuela and showed more appetite for leisure product stocks to start 2026. See our latest analysis for YETI Holdings. That risk-on mood has arrived on top of strong recent momentum for YETI, with a 90-day share price return of 53.19% and a 1-year total shareholder return of 31.42%, even though the 5-year total shareholder return of 36.53%...

What the recent caution around Sonic Automotive means for investors Recent market commentary has put Sonic Automotive (SAH) back on investors’ radar, as short-term pressure, used car market normalization, and questions around EchoPark’s long-term profitability have made the upcoming quarters feel particularly important. See our latest analysis for Sonic Automotive. The recent caution around EchoPark and used car normalization comes against a mixed backdrop, with a 1-day share price return of...

Harley-Davidson recently reported a strong quarter, with revenue rising 16.5% year on year and both EPS and EBITDA coming in above analyst expectations, while also showcasing its products at the 2026 Washington, D.C. Auto Show as part of a broader focus on innovation and next-generation mobility. This combination of robust financial performance and increased visibility in an auto show that highlighted electric and sustainable transportation underscores how Harley-Davidson is trying to stay...

PHINIA (PHIN) has drawn attention after recent share price performance, with the stock showing positive returns over the past week, month and past 3 months. You might be wondering how that lines up with fundamentals. See our latest analysis for PHINIA. PHINIA's recent strength, including a 22.31% 30 day share price return and a $67.97 latest share price, sits alongside a 45.21% 1 year total shareholder return, suggesting momentum has been building over the past year. If PHINIA's recent move...

JetBlue Airways has recently overhauled its route network, adding new year-round nonstop services from Fort Lauderdale to Orlando and Dallas–Fort Worth, increasing Fort Lauderdale–LaGuardia frequencies, launching a future New York JFK–Cleveland route, and permanently ending several other routes after March 11, 2026. This shift signals a reallocation of capacity toward leisure-heavy Florida corridors and key connection points, while trimming routes that appear less aligned with JetBlue’s...

Ingevity Corporation has now completed the sale of its North Charleston crude tall oil refinery assets and most of its Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC, as part of a portfolio reshaping plan. This move marks a clear shift toward higher-margin activated carbon and pavement technologies, aiming to simplify operations and reduce earnings volatility across the business. Next, we’ll examine how divesting the crude tall oil refinery and...

Recently, commentary on the US Oil and Gas – Exploration and Production industry highlighted more durable natural gas demand supported by LNG exports and rising power needs, emphasizing that firms like Antero Resources could see more stable cash flows as a result. Antero Resources appears particularly positioned within this backdrop because its affiliate Antero Midstream helps secure transportation and market access, while analyst earnings estimates for 2026 point to meaningful...

Interest in SI-BONE (SIBN) picked up after Jim Cramer called the stock a “great, great speculation” on his investment program, putting a spotlight on this medical device company’s sacropelvic disorder focus. See our latest analysis for SI-BONE. The recent media attention lands on a stock that already has some momentum, with a 90 day share price return of 41.27% and a 1 year total shareholder return of 45.00%. However, the 5 year total shareholder return of 27.42% and the latest 1 day share...

Recently, John Wiley & Sons announced the launch of the Nanalysis Edition of its KnowItAll spectral analysis software, a customized platform that integrates Nanalysis’s NMR database to streamline workflows for benchtop NMR users across pharmaceutical, biotechnology, materials science, and quality control fields. This tailored software release deepens Wiley’s role in specialized scientific tools, broadening its reach beyond publishing into workflow-critical digital solutions for laboratory...

Amylyx Pharmaceuticals announced in early January 2026 that it has selected AMX0318, a long-acting GLP-1 receptor antagonist discovered with Gubra A/S, as a development candidate for post-bariatric hypoglycemia and certain other rare diseases following extensive preclinical evaluation. The program’s progression toward investigational new drug–enabling studies and a potential 2027 IND filing, alongside more than US$50.00 million in potential milestones and royalties for Gubra, highlights...

American International Group (AIG) is back in focus after the company said Chairman and CEO Peter Zaffino will step down as chief executive by mid 2026, with Eric Andersen arriving as President and CEO elect. See our latest analysis for American International Group. The leadership news landed alongside a sharp single day share price decline of about 7% earlier this week, and a softer 7 day and 90 day share price return. However, the 1 year and 5 year total shareholder returns of 11.39% and...

Cogent Communications Holdings (CCOI) has attracted attention after recent share price moves, with the stock showing mixed short term and past 3 months performance that contrasts with its longer term total return record. See our latest analysis for Cogent Communications Holdings. The recent 1 month share price return of 4.10% and 7 day share price return of 3.52% sit against a 90 day share price return decline of 46.92% and a 1 year total shareholder return decline of 67.42%. This combination...

CG Oncology has announced an expedited timeline, with topline data from its Phase 3 PIVOT-006 trial of intravesical cretostimogene grenadenorepvec in intermediate-risk non-muscle invasive bladder cancer now expected in the first half of 2026, alongside ongoing Phase 2 and Phase 3 studies and an Expanded Access Program in North America. This is the first randomized Phase 3 trial in this intermediate-risk bladder cancer population under AUA/SUO guideline definitions, positioning cretostimogene...

In recent months, analysts at major banks including Citigroup and UBS have reiterated positive ratings on Olema Pharmaceuticals, citing confidence in its clinical-stage pipeline and strengthened balance sheet following a roughly US$218.5 million public offering in November 2025. An interesting angle for investors is Olema’s inclusion on Citigroup’s 90-day catalyst watchlist, highlighting expectations around upcoming clinical and corporate milestones. Next, we’ll examine how Olema’s addition...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...